HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frédéric Di Fiore Selected Research

Therapeutics

6/2021Efficacy and safety of anti-vascular endothelial growth factor therapies in older patients for first line treatment of metastatic renal cell carcinoma.
1/2020Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, non-comparative phase II study.
1/2020Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
1/2019Impact of Taxanes, Endocrine Therapy, and Deleterious Germline BRCA Mutations on Anti-müllerian Hormone Levels in Early Breast Cancer Patients Treated With Anthracycline- and Cyclophosphamide-Based Chemotherapy.
12/2018FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
11/2018ERBB3-Activating Mutations in Small Bowel Adenocarcinomas.
1/2018Correction to: Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
1/2018[Clinical relevance of ESR1 circulating mutations detection in hormone receptor positive metastatic breast cancer].
8/2017Impact of new generation hormone-therapy on cognitive function in elderly patients treated for a metastatic prostate cancer: Cog-Pro trial protocol.
5/2017Evaluating lanreotide as maintenance therapy after first-line treatment in patients with non-resectable duodeno-pancreatic neuroendocrine tumours.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Frédéric Di Fiore Research Topics

Disease

25Neoplasms (Cancer)
01/2022 - 01/2007
13Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 08/2008
10Breast Neoplasms (Breast Cancer)
01/2020 - 03/2009
7Esophageal Neoplasms (Esophageal Cancer)
01/2017 - 06/2006
6Adenocarcinoma
01/2021 - 01/2007
4Disease Progression
01/2022 - 03/2009
4Glioblastoma (Glioblastoma Multiforme)
03/2021 - 02/2019
4Carcinoma (Carcinomatosis)
03/2014 - 04/2005
3Renal Cell Carcinoma (Grawitz Tumor)
06/2021 - 03/2015
3Neoplasm Metastasis (Metastasis)
05/2017 - 08/2008
3Deglutition Disorders (Dysphagia)
11/2007 - 08/2005
2Thrombocytopenia (Thrombopenia)
08/2020 - 02/2019
2Prostatic Neoplasms (Prostate Cancer)
01/2018 - 08/2017
2Weight Loss (Weight Reduction)
03/2014 - 11/2007
2Microsatellite Instability
04/2013 - 09/2009
2Hemorrhage
06/2005 - 01/2004
1Colonic Neoplasms (Colon Cancer)
01/2022
1Circulating Neoplastic Cells
12/2021
1Esophageal Squamous Cell Carcinoma
01/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2018
1Interstitial Lung Diseases (Interstitial Lung Disease)
12/2018
1Second Primary Neoplasms (Neoplasms, Second)
12/2018
1Adenoma (Adenomas)
02/2018
1Cognitive Dysfunction
08/2017
1Chronic Renal Insufficiency
09/2015
1Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia)
03/2015
1Fibrosis (Cirrhosis)
08/2013
1Hepatocellular Carcinoma (Hepatoma)
08/2013
1Necrosis
08/2013
1Thrombosis (Thrombus)
08/2013

Drug/Important Bio-Agent (IBA)

9Hormones (Hormone)IBA
01/2020 - 11/2015
6Cell-Free Nucleic AcidsIBA
01/2022 - 10/2015
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2010
4Irinotecan (Camptosar)FDA LinkGeneric
12/2020 - 01/2009
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 01/2009
4Cetuximab (Erbitux)FDA Link
03/2016 - 01/2009
3Biomarkers (Surrogate Marker)IBA
01/2020 - 02/2017
3Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2018 - 01/2009
3Fluorouracil (Carac)FDA LinkGeneric
12/2018 - 06/2006
3Aromatase InhibitorsIBA
01/2018 - 11/2015
2Biological ProductsIBA
12/2021 - 02/2010
2Circulating Tumor DNAIBA
12/2021 - 11/2015
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 01/2009
2folfirinoxIBA
01/2021 - 12/2018
2Sorafenib (BAY 43-9006)FDA Link
12/2020 - 08/2013
2Temozolomide (Temodar)FDA LinkGeneric
08/2020 - 02/2019
2Leucovorin (Folinic Acid)FDA Link
12/2018 - 03/2016
2Trastuzumab (Herceptin)FDA Link
11/2018 - 03/2009
2Serum AlbuminIBA
03/2014 - 11/2007
2AntibodiesIBA
08/2010 - 01/2009
2Panitumumab (Vectibix)FDA Link
08/2010 - 01/2009
1Fetal Proteins (Fetoprotein)IBA
01/2022
1Telomerase (Telomerase Reverse Transcriptase)IBA
03/2021
1Aromatase (CYP19)IBA
01/2020
1PlatinumIBA
01/2020
1Paclitaxel (Taxol)FDA LinkGeneric
01/2020
1epidermal growth factor receptor VIIIIBA
01/2020
1AnthracyclinesIBA
01/2019
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2019
1taxaneIBA
01/2019
1Taxoids (Taxanes)IBA
01/2019
1CarbohydratesIBA
01/2019
1AntigensIBA
01/2019
1GemcitabineFDA Link
12/2018
1AfatinibIBA
11/2018
1Lapatinib (GW572016)FDA Link
11/2018
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2018
1Edetic Acid (EDTA)FDA Link
09/2017
1AndrogensIBA
08/2017
1IceIBA
02/2017
1Estrogen ReceptorsIBA
11/2015
1EverolimusFDA Link
03/2015
1Messenger RNA (mRNA)IBA
04/2013
13' Untranslated Regions (3' UTR)IBA
04/2013
1polyadenineIBA
04/2013
1Formaldehyde (Formol)FDA Link
08/2011
1Codon (Codons)IBA
08/2011
1ParaffinIBA
08/2011

Therapy/Procedure

15Therapeutics
06/2021 - 03/2003
14Drug Therapy (Chemotherapy)
12/2020 - 06/2006
8Chemoradiotherapy
03/2016 - 06/2006
6Radiotherapy
02/2019 - 06/2006
5Adjuvant Chemotherapy
01/2022 - 01/2006
4Palliative Care (Palliative Therapy)
08/2013 - 10/2006
3Stents
11/2007 - 08/2005
2Immunotherapy
06/2021 - 09/2009
2Aftercare (After-Treatment)
10/2017 - 08/2017
2Photochemotherapy (Photodynamic Therapy)
09/2010 - 09/2008
1Colectomy
01/2022
1Drug Tapering
01/2021
1Catheters
01/2020
1Vascular Access Devices (Arterial Line)
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
12/2018
1Neoadjuvant Therapy
02/2018
1Castration
08/2017
1Precision Medicine
02/2017
1Transcutaneous Electric Nerve Stimulation (TENS)
01/2017
1Central Venous Catheters
04/2016
1Hepatectomy
08/2013
1Molecular Targeted Therapy
08/2013